Sifalimumab, a Human Anti–Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study: A Phase I Randomized, Controlled, Dose-Escalation Study

Sifalimumab, a Human Anti–Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study: A Phase I Randomized, Controlled, Dose-Escalation Study

Bibliographic Details
Main Authors: Petri, Michelle, Wallace, Daniel J, Spindler, Alberto, Chindalore, Vishala, Kalunian, Kenneth, Mysler, Eduardo, Neuwelt, C Michael, Robbie, Gabriel, White, Wendy I, Higgs, Brandon W, Yao, Yihong, Wang, Liangwei, Ethgen, Dominique, Greth, Warren
Format: Online
Language:English
Published: Wiley Subscription Services, Inc., A Wiley Company 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654174/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654174/

Similar Items